Abstract
Sarcopenia is defined as the loss of skeletal muscle mass, quality and function associated with ageing.1 The diagnosis and health implications of obesity are well established. Sarcopenic obesity refers to the combined diagnoses of sarcopenia and obesity. It appears to increase the risk of musculoskeletal and cardiometabolic conditions, morbidity, and early mortality. A/Prof Justin Keogh, A/Prof Neil Chapman and A/Prof Hayley O’Neill discuss screening, diagnosis and the evidence-base for current treatment options. Diabetes Management Journal is the official journal of Diabetes Australia and limits reading access to only health care professionals with current AHPRA numbers.
| Original language | English |
|---|---|
| Pages (from-to) | 17-19 |
| Number of pages | 3 |
| Journal | Diabetes Management Journal |
| Publication status | Published - Nov 2024 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Sarcopenic obesity: What it is, why it is important and how we manage it'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver